Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients
Status:
Recruiting
Trial end date:
2028-02-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, phase I/II study to determine the efficacy and safety of CRC01 in
adult patients with relapsed or refractory large B-cell lymphoma.